Pulse nav.journalClub 활발한 토론 트렌드 탐색 질문 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

개인정보 처리방침

홈 탐색 nav.journalClub 트렌드

⌘+K

July 23, 2018

다양한 암 유형에서 동종 재조합 관련 유전자 변이의 유병률

Key Points

Key points are not available for this paper at this time.

Abstract

HR-DDR 변이는 21가지 암 계통에서 종양의 17.4%에서 관찰되어 폴리-ADP 리보스 중합효소 억제제, DNA 손상 화학요법 및 ATR 억제제와 같은 새로운 요법을 포함한 HRD 지향 치료의 역할을 탐색할 수 있는 경로를 제공합니다.

Like

Bookmark

Share

Like

Bookmark

Share

Cite This Study

Heeke 외. (Mon,) 이 문제를 연구했습니다.

synapsesocial.com/papers/69da11319a6164e50fa3db84 https://doi.org/https://doi.org/10.1200/po.17.00286

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology2015 · 32,255 citations
2BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients2011 · 400 citations
3Identification of frequent somatic mutations in inflammatory breast cancer2017 · 45 citations
4Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial2016 · 1,200 citations
5Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy2015 · 246 citations

다양한 암 유형에서의 동질적 재조합 관련 유전자 변이의 유병률 | Synapse